The influence of genetic background on the phenotypes of embryonic lethality and neural defects has also previously been reported in homozygous Men1-/- mouse embryos (18), implicating a role for genetic modifiers in MEN1 syndrome. This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.